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Abstract
α-Crystallin is a member of the small heat shock protein (sHsp) family which exists as a
multimer of αA- and αB-crystallin subunits in the ratio of 3:1 in the lens, where it was
first identified. It is an intracellular molecular chaperone, capable of interacting with a
multitude of target proteins to prevent their aggregation and precipitation. Initially
considered to be solely a lens protein, individual αA- and αB-crystallin proteins have
since been found in other organs with αB-crystallin in particular appearing to play a
role in many neurodegenerative disorders (e.g. Alzheimer’s, Parkinson’s and
Creutzfeldt-Jakob diseases). Due to the dynamic nature of α-crystallin oligomers and
the propensity for subunit exchange, crystallisation of the protein has been impossible.
As a result, the mechanisms by which α-crystallin functions remain elusive, as does a
complete picture of the chaperone’s quaternary structure.

In this study, recombinant human αA- and αB-crystallin were expressed and purified
using conventional methods (Horwitz, J., Huang, Q-L., Ding, L. and Bova, M. P. (1998)
Methods in Enzymology 290:363-383). A series of mutants of αA- and αB-crystallin
were also constructed, with mutation sites concentrated in the C-terminal region of the
protein and in particular the solvent-exposed and flexible C-terminal extension. This
extension, which comprises 10 and 12 amino acids in human αA- and αB-crystallin,
respectively, behaves in a similar manner to an unstructured peptide in solution.
Previous NMR spectroscopic studies have indicated that it serves a crucial role in
binding target proteins.
C-Terminal extension mutants K175L, K174A/K175A, E164A/E165A, I159A/I161A
and R163STOP (αB-crystallin) and S172L, T168L and R163STOP mutants
xv

(αA-crystallin) were produced and purified in the same manner as for the wildtype
proteins. The expected masses of mutants were confirmed by electrospray mass
spectrometry (ESI-MS). Complete purification, however, of S172L and R163STOP αAcrystallin was not achieved due to decreased aggregate size and excessive
hydrophobicity, respectively. Purified wildtype and mutant proteins were structurally
and functionally characterised using a variety of spectroscopic techniques. These
included chaperone assays under both reduction and heat stress with insulin and βLcrystallin

as

target

proteins,

respectively,

intrinsic

tryptophan

fluorescence

spectroscopy, far- and near-UV circular dichroism (CD) spectroscopy, thermostability
studies, size-exclusion high-performance liquid chromatography (HPLC), mass
spectrometry and nuclear magnetic resonance (NMR) spectroscopy. Many of the αBcrystallin mutants purified successfully and provided insight into specific amino acid
residues that are important for the chaperone action of the protein. These include the “IX-I motif” at the C-terminal end of the protein which is highly conserved throughout
sHsps and is thought to be critical for oligomeric assembly. Mutation of both isoleucine
residues in the αB-crystallin I-X-I motif to alanine resulted in a protein which formed
larger oligomeric complexes than the wildtype protein. Truncation of the C-terminal
extension of αB-crystallin resulted in a protein with severely impaired chaperone
ability, increased tendency to aggregate and disrupted secondary, tertiary and quaternary
structures. These results suggest that the polar and flexible C-terminal extension is also
necessary for uniform oligomeric assembly as well as for the solubility of α-crystallin
as a whole. Chaperone and thermostability studies on the double glutamic acid mutant
(E164A/E165A) showed that these highly charged residues are critical to the solubility
of αB-crystallin at higher temperature. Consistent with this, ion-pairs and the formation
of salt bridges between charged amino acids on the surfaces of thermophilic proteins are
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thought to be responsible for their increased thermostability. Recombinant human αAand αB-crystallin were uniformly 15N-labelled for the purposes of 2D Nuclear Magnetic
Resonance spectroscopy (NMR) studies. Measurement of 15N relaxation time constants
(T1 and T2) and 15N Nuclear Overhauser Effects (NOEs) for both wildtype proteins and
the K175L and I159/I161A mutants of αB-crystallin have provided detailed information
on the relative flexibilities of residues in the protein's C-terminal extension. Substitution
of a leucine residue for the C-terminal lysine (K175) increased extreme C-terminal
mobility and substitution of the isoleucine pair of the I-X-I motif with alanine residues
led to a disruption of flexibility throughout the C-terminal extension. 15N T1 and T2 and
15

N NOE values were also determined for 15N-labelled αA-crystallin in the presence of

reduced α-lactalbumin in order to gain information on changes in the flexibility of the
C-terminal extension upon chaperone interaction with a stressed target protein. Upon
formation of a chaperone-target protein complex, the flexibilities of C-terminal residues
of αA-crystallin were equalised across the extension indicating that the entire extension
was involved in interaction with the target protein to some extent.
The R120G αB-crystallin mutant, which is associated with desmin-related myopathy
and cataract in humans was also expressed and purified for the purposes of further
structural characterisation. Previous studies on this mutant have provided some
ambiguous results with regard to its chaperone ability and general structural stability. It
was found that in addition to being intrinsically unstable and susceptible to unfolding,
R120G αB-crystallin underwent C-terminal proteolysis with time. Furthermore, R120G
αB-crystallin exhibited marked substrate specificity and in fact, acted as an “antichaperone” in the presence of reduced α-lactalbumin. Under these conditions, R120G
αB-crystallin promoted the aggregation of the molten globule state of α-lactalbumin
and co-precipitated with it out of solution. This study, therefore provided several
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insights into structural and functional aspects of α-crystallin small heat shock chaperone
proteins.
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